Log in to save to my catalogue

Therapeutic targeting of HER2–CB₂R heteromers in HER2-positive breast cancer

Therapeutic targeting of HER2–CB₂R heteromers in HER2-positive breast cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6397550

Therapeutic targeting of HER2–CB₂R heteromers in HER2-positive breast cancer

About this item

Full title

Therapeutic targeting of HER2–CB₂R heteromers in HER2-positive breast cancer

Publisher

Washington: National Academy of Sciences

Journal title

Proceedings of the National Academy of Sciences - PNAS, 2019-02, Vol.116 (9), p.3863-3872

Language

English

Formats

Publication information

Publisher

Washington: National Academy of Sciences

More information

Scope and Contents

Contents

Although human epidermal growth factor receptor 2 (HER2)-targeted therapies have dramatically improved the clinical outcome of HER2-positive breast cancer patients, innate and acquired resistance remains an important clinical challenge. New therapeutic approaches and diagnostic tools for identification, stratification, and treatment of patients at...

Alternative Titles

Full title

Therapeutic targeting of HER2–CB₂R heteromers in HER2-positive breast cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6397550

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6397550

Other Identifiers

ISSN

0027-8424

E-ISSN

1091-6490

DOI

10.1073/pnas.1815034116

How to access this item